Document is current
Any future updates will be listed below
-
Authors
Hong, Christy
Schubert, Michael https://orcid.org/0000-0002-6862-5221
Tijhuis, Andréa E.
Requesens, Marta https://orcid.org/0000-0001-5559-8845
Roorda, Maurits https://orcid.org/0000-0001-8779-4680
van den Brink, Anouk https://orcid.org/0000-0003-1316-8673
Ruiz, Lorena Andrade
Bakker, Petra L.
van der Sluis, Tineke
Pieters, Wietske https://orcid.org/0000-0002-0375-5789
Chen, Mengting
Wardenaar, René https://orcid.org/0000-0001-9891-1897
van der Vegt, Bert https://orcid.org/0000-0002-2613-1506
Spierings, Diana C. J. https://orcid.org/0000-0001-8403-474X
de Bruyn, Marco https://orcid.org/0000-0001-9819-9131
van Vugt, Marcel A. T. M. https://orcid.org/0000-0002-3202-4678
Foijer, Floris https://orcid.org/0000-0003-0989-3127
- License Information
-
More Information
Article History
Received: 1 September 2021
Accepted: 10 May 2022
First Online: 15 June 2022
Competing interests
: M.A.T.M.v.V. has acted on the Scientific Advisory Board of Repare Therapeutics, which is unrelated to this work. B.v.d.V has acted as a consultant or scientific advisory board member (on request) for Visiopharm, Philips, MSD/Merck and as a speaker for Visiopharm, Diaceutics and MSD/Merck for which UMCG was compensated. This is all unrelated to this work. The other authors declare no competing interests.
